Company Filing History:
Years Active: 2022
Title: Kailei Cao - Innovator in Ophthalmic Treatments
Introduction
Kailei Cao is a notable inventor based in Hefei, China. He has made significant contributions to the field of ophthalmic treatments, particularly through his innovative patent related to cyclosporine eye gel. His work exemplifies the intersection of science and practical application in the medical field.
Latest Patents
Kailei Cao holds a patent for a treatment process of cyclosporine eye gel. This process involves several steps, including the addition of carbomer to water, thorough stirring, and homogenization. After preparing the carbomer base, it undergoes moist heat sterilization and vacuum degassing. The pH of the base is adjusted to between 5.0 and 9.0 using filtered sodium hydroxide solution. The formulation is completed by mixing polyoxyl 35 castor oil, cyclosporin A raw material, 1,2-propanediol, and water in a suitable ratio, resulting in a clear solution. This innovative approach facilitates industrial production by performing sterilization and filtration before adding carbomer.
Career Highlights
Kailei Cao is associated with Zhaoke (Guangzhou) Ophthalmic Drug Company Limited, where he continues to develop and refine his inventions. His dedication to improving ophthalmic treatments has positioned him as a key figure in the industry.
Collaborations
Kailei has collaborated with notable colleagues, including Gang Li and Xiaoyi Li, who contribute to his innovative projects and research efforts.
Conclusion
Kailei Cao's contributions to the field of ophthalmic treatments through his patent for cyclosporine eye gel highlight his innovative spirit and commitment to advancing medical science. His work not only enhances treatment options but also paves the way for future developments in ophthalmology.